All In Biotech

Drug Trial Radar · NCT00947297

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

A Phase 3, Open-Label Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

Last checked: Nov 20, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

60

Actual

Start

Nov 2009

Primary completion

Sep 2011

Study completion Nov 2011

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Jul 28, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This was a long-term safety study HPN-100 in urea cycle disorder (UCD) subjects. Subjects were assessed regularly for safety and control of their venous ammonia. Hyperammonemic events were characterized with respect to contributing factors, such as intercurrent illness, diet, and noncompliance with medication.

Conditions

  • Urea Cycle Disorders

Interventions

  • HPN-100Drug

    HPN-100 is a triglyceride that has a similar mechanism of action as NaPBA. It is a liquid with minimal taste and odor. Three teaspoons of HPN-100 (\~17.4 mL) delivers equivalent of PBA that 40 tablets of NaPBA do.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Adverse Events (Number of Participants Who Experienced Any AE Considered Related to Study Drug)Time frame: 1 year

Locations

22 sites in 2 countries. Site status is shown where the registry gives one.

  • Long Beach Memorial

    Long Beach, California

  • UCLA

    Los Angeles, California

  • Stanford University

    Stanford, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Yale School of Medicine

    New Haven, Connecticut

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • University of Florida

    Gainesville, Florida

  • Univeristy of Iowa

    Iowa City, Iowa

  • Maine Medical Center

    Portland, Maine

  • SNBL-Clinical Pharmacology Center

    Baltimore, Maryland

  • Tufts-New England Medical Center

    Boston, Massachusetts

  • University of Minnesota Medical Center

    Minneapolis, Minnesota

  • Mount Sinai School of Medicine

    New York, New York

  • Westchester Medical Center

    Valhalla, New York

  • University Hospitals Case Medical Center

    Cleveland, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • University of Pittsburgh

    Pittsburgh, Pennsylvania

  • Baylor College of Medicine

    Houston, Texas

  • University of Utah

    Salt Lake City, Utah

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • The Hospital for Sick Children

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.